Document Detail


Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy.
MedLine Citation:
PMID:  19655176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Knowledge of oral mucositis (OM) in patients with acute leukemia (AL) and chemotherapy (CT) has remained limited. Thus, a prospective, longitudinal study was undertaken to characterize clinical features, associated risk factors, and behavior of OM in a cohort of AL patients starting CT. METHODS: Prospective and longitudinal study. A cohort of patients, older than 15 years of age with AL, scheduled to receive CT, was followed from March 2006 to October 2007. At baseline and three times per week, for 21 days, patients had an oral examination performed using the Oral Mucositis Assessment Scale (OMAS); also, oral pain and difficulty to swallow were recorded using a visual analog scale. Weekly, salivary flow measurements (Schirmer's test modified version) were done. RESULTS: A cohort of 29 AL patients was followed for a median time of 21 (range, 14-53) days; 12 (41.4%) developed OM, with a mean OMAS score of 0.181 (SD +/- 0.56) and a mean peak OMAS score of 1.8 (SD +/- 0.56). The OM onset mean time was 9.8 (range, 2-20, SD +/- 6.09) days, with a mean duration of 7 (range, 3-14, SD +/- 4.15) days. OM was significantly correlated with salivary flow [rs = 0.420 (P = 0.0051)], oral pain [rs = 0.47 (P < 0.0001)], ability to swallow [rs = 0.36 (P = 0.0001)], and type of food intake [rs = 0.38 (P < 0.0001)]. CONCLUSIONS: OM is a frequent and early side effect of CT closely correlated with oral pain, difficulty to swallow, and impairment in food intake.
Authors:
Velia Ramírez-Amador; Gabriela Anaya-Saavedra; Erick Crespo-Solís; Esther Irigoyen Camacho; Imelda González-Ramírez; Sergio Ponce-de-León
Related Documents :
19079316 - A prospective randomized controlled trial comparing pcr-based and empirical treatment w...
6187216 - Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir.
18456556 - Prediction of delayed treatment response in pulmonary tuberculosis: use of time to posi...
17051456 - Effectiveness and tolerability of a standardized extract from ageratina pichinchensis o...
19760226 - Iilizarov external fixator for bilateral severe flexion deformity of the knee in haemop...
21098196 - Temporal evolution of mri findings after arthroscopic rotator cuff repair.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-08-06
Journal Detail:
Title:  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer     Volume:  18     ISSN:  1433-7339     ISO Abbreviation:  Support Care Cancer     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-03-29     Completed Date:  2010-07-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9302957     Medline TA:  Support Care Cancer     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  639-46     Citation Subset:  IM    
Affiliation:
Health Care Department, Universidad Autónoma Metropolitana-Xochimilco, 04960 Mexico City, Mexico. rava1863@correo.xoc.uam.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adolescent
Adult
Antineoplastic Agents / adverse effects*
Female
Humans
Leukemia / drug therapy*
Longitudinal Studies
Male
Middle Aged
Prospective Studies
Risk Factors
Stomatitis / chemically induced,  physiopathology*
Young Adult
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A device to improve the Schleger and Turner method for sweating rate measurements.
Next Document:  Outcome of excisional surgeries for the patients with spinal metastases.